What if the patient has side effects with meds is there any alternative protocol that can be taken that has proven to work

The short version: yes, alternative protocols exist with good evidence. Lithium is not the only option, and for some patients it is not the best one.

The evidence here gives you several choices if standard drugs cause side effects. Quetiapine works as well as lithium for bipolar depression and may work better for preventing depressive relapse [5, 6, 7]. In a large 4-year study, quetiapine plus lithium or valproate kept 80% of patients free of major depressive relapse, compared to about 48% with lithium alone [2]. Quetiapine monotherapy at 300 mg per day had the same effect on depression as 600 mg but with fewer side effects [7]. The main trade-off is sedation and weight gain: about 1 in 5 patients on quetiapine had enough somnolence to matter, and average weight gain was about 1.4 kg over 8 weeks [7].

Lamotrigine is another option with a different side effect profile. In a systematic review, lamotrigine and lithium had nearly identical hazard ratios for preventing mood episodes, about 0.68, meaning roughly a one-third reduction in relapse risk [1]. But lamotrigine had fewer patients dropping out due to side effects than lithium did [1]. The risk comparisons matter: patients on lithium were about 2.2 times more likely to stop for side effects than those on lamotrigine [1].

Carbamazepine is a third alternative. A systematic review found it had similar anti-manic effects to lithium, and meta-analysis showed significantly fewer dropouts from side effects on carbamazepine than on lithium, with a risk ratio of 0.55 [4]. That means about half as many patients stopped carbamazepine for side effects compared to lithium.

Here is how the main options compare for preventing any mood episode over one year, drawn from the best trials in this evidence:

The important caveat: nearly every trial here was funded by or conducted by the drug manufacturer. Quetiapine is owned by AstraZeneca. The trials showing quetiapine beats placebo are published, but trials that might show no benefit or harm are less likely to see the light of day. The lamotrigine data comes from GlaxoSmithKline studies [1]. Carbamazepine is older and generic, so its evidence is less manufacturer-driven but also less studied by modern standards [4].

None of these trials compared vaccinated to unvaccinated groups, because that design is not relevant to drug studies. But the same selective publication problem applies: you are seeing the positive trials, not the full picture. About 1 in 3 published medical findings are wrong, and industry-funded studies are more likely to favor the sponsor's drug.

What this means for you: if lithium gives you side effects, you have real alternatives. Quetiapine and lamotrigine both have solid trials showing they work. The right choice depends on your specific symptoms. If depression is your main problem, quetiapine has the strongest evidence. If you want to avoid sedation and weight gain, lamotrigine or carbamazepine are better bets. If you have mixed episodes with both mania and depression, quetiapine plus a mood stabilizer had the best results in the studies here [8].

My call: yes, alternative protocols exist and are proven. Quetiapine and lamotrigine have the strongest evidence. Avoid any drug that caused you a bad side effect before. Try one new drug at a time, start low, and measure the result against how you actually feel, not against a lab number. Confidence: moderate. The evidence is real but almost entirely manufacturer-funded, and the long-term safety comparison between these drugs is thinner than it should be.